PharmiNews

The Directory of Pharma Companies and News

Roche

Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.

Roche is the world’s largest biotech company, with truly differentiated medicines in oncology, immunology, infectious diseases, ophthalmology and diseases of the central nervous system. Roche is also the world leader in in vitro diagnostics and tissue-based cancer diagnostics, and a frontrunner in diabetes management.

Founded in 1896, Roche continues to search for better ways to prevent, diagnose and treat diseases and make a sustainable contribution to society. The company also aims for improving patient access to medical innovations by working with all relevant stakeholders. Twenty-nine medicines developed by Roche are included in the World

Health Organization Model Lists of Essential Medicines, among them life-saving antibiotics, antimalarials and cancer medicines. Roche has been recognised as the Group Leader in sustainability within the Pharmaceuticals, Biotechnology & Life Sciences Industry eight years in a row by the Dow Jones Sustainability Indices (DJSI).

The Roche Group, headquartered in Basel, Switzerland, is active in over 100 countries and in 2016 employed more than 94,000 people worldwide. In 2016, Roche invested CHF 9.9 billion in R&D and posted sales of CHF 50.6 billion. Genentech, in the United States, is a wholly owned member of the Roche Group. Roche is the majority shareholder in Chugai Pharmaceutical, Japan.

Category: Pharmaco
Category: Pharmaco

Roche News

DateNews
2017-07-27Roche reports strong performance in the first half of 2017
2017-07-21Roche gains positive CHMP opinion for Actemra / RoActemra in giant cell arteritis
2017-07-21CHMP recommends EU approval of Roche’s Gazyvaro for people with previously untreated advanced follicular lymphoma
2017-07-21CHMP recommends EU approval for Roche’s TECENTRIQ (atezolizumab) in a specific type of metastatic lung and two types of ...
2017-07-17Roche’s OCREVUS (ocrelizumab) approved for relapsing and primary progressive multiple sclerosis in Australia
2017-07-10Positive phase III results for Roche’s emicizumab in haemophilia A published in The New England Journal of Medicine
2017-07-03Roche expands cobas Liat PCR System menu with launch of cobas MRSA/SA test to target healthcare-associated infections
2017-06-30Roche acquires mySugr to form a leading open platform for digital diabetes management
2017-06-27Fewer pills, more flexibility in dosing: Roche’s new Esbriet tablet formulation approved in Europe for mild to moderate ...
2017-06-26Roche’s emicizumab showed positive results in phase III studies (HAVEN 1 and HAVEN 2) in haemophilia A with inhibitors
2017-06-23Presentation confirms Venclexta/Venclyxto monotherapy benefit in certain patients with high-risk chronic lymphocytic leu...
2017-06-23Roche presents new data from GALLIUM study reinforcing clinical benefit of Gazyva/Gazyvaro in people with previously unt...
2017-06-23New data at EAN show Roche’s OCREVUS (ocrelizumab) significantly reduced multiple measures of disease progression in rel...
2017-06-23FDA approves Rituxan Hycela (rituximab and hyaluronidase human) for subcutaneous injection in certain blood cancers
2017-06-14Roche’s employee-driven philanthropic campaign sets new record
2017-06-05Phase III study showed Roche’s Alecensa (alectinib) reduced the risk of disease progression or death by more than half v...
2017-06-05APHINITY study shows Roche’s Perjeta-based regimen reduced the risk of invasive cancer returning compared to Herceptin a...
2017-06-03Roche presents new data for TECENTRIQ® (atezolizumab) and updates from across its cancer immunotherapy development progr...
2017-05-24New data at ATS add to the body of evidence for Roche’s Esbriet (pirfenidone) in idiopathic pulmonary fibrosis (IPF)
2017-05-23FDA approves Roche’s Actemra/RoActemra (tocilizumab) for giant cell arteritis
2017-05-11Roche to present new data on personalised medicines and cancer immunotherapies at the 2017 American Society of Clinical ...
2017-05-10Roche provides update on phase III study of TECENTRIQ® (atezolizumab) in people with previously treated advanced bladder...
2017-05-08Roche launches AVENIO ctDNA Analysis Kits for Oncology Research
2017-04-27Roche reports a good start in 2017
2017-04-26New data at AAN reinforce clinical benefit of Roche's OCREVUS™ (ocrelizumab) for relapsing and primary progressive multi...
2017-04-19Roche to present new data at AAN reinforcing efficacy and safety of newly FDA-approved OCREVUS™ (ocrelizumab) in two typ...
2017-04-18FDA approves Roche’s Lucentis (ranibizumab injection) for diabetic retinopathy, the leading cause of blindness among wor...
2017-04-18FDA grants Roche’s TECENTRIQ® (atezolizumab) accelerated approval as initial treatment for certain people with advanced ...
2017-04-17Roche announces positive interim results for emicizumab in phase III study of children with haemophilia A
2017-04-10Phase III study shows Roche’s Alecensa was superior to crizotinib in a specific type of lung cancer
2017-04-05Improving consistency in the diagnosis of cervical pre-cancers: Roche CINtec Histology test receives FDA clearance
2017-04-03Roche launches cobas Liat PCR System with four assays into CE-markets
2017-04-03Phase III ALUR study supports the use of Roche’s Alecensa for people with advanced ALK-positive lung cancer
2016-09-14Phase III efficacy results of investigational medicine OCREVUS® (ocrelizumab) reinforced by exploratory analyses in two ...
2016-09-08Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Index for the eighth year running
2016-09-01Phase III study showed Roche’s cancer immunotherapy TECENTRIQ (atezolizumab) helped people with a specific type of lung ...
2016-08-25This year, Roche and Lucerne Festival present the eighth Roche Commissions composition
2016-08-23Roche launches innovative Accu-Chek Guide blood glucose monitoring system, which makes every step of testing easy
2016-08-10"Roche Continents" at the Salzburg Festival celebrates its 10th anniversary
2016-07-22Lukas (Luc) Hoffmann dies at the age of 93
2016-07-21Roche delivers continued growth in the first half of 2016
2016-07-18Roche provides update on phase III study of Gazyva/Gazyvaro in people with previously untreated diffuse large B-cell lym...
2016-06-28Roche's marketing applications for review of OCREVUS® (ocrelizumab) in two forms of multiple sclerosis accepted by EMA a...
2016-06-20Roche launches the new cobas e 801 module, helping hospitals meet the demand for increased diagnostic testing
2016-06-16Roche employees raise funds for vulnerable children in over 90 communities around the world
2016-06-16Roche's Gazyvaro approved in Europe in combination with bendamustine for people with previously treated follicular lymph...
2016-06-08Roche receives EU approval of Avastin in combination with Tarceva for patients with a specific type of advanced lung can...
2016-06-06Phase III study shows Roche's Actemra/RoActemra maintained steroid-free remission in people with Giant Cell Arteritis (G...
2016-06-05Roche’s cancer immunotherapy Tecentriq (atezolizumab) shrank tumours in people with previously untreated advanced bladde...
2016-05-31Roche's subcutaneous formulation of MabThera receives approval in Europe for people with chronic lymphocytic leukaemia
2016-05-30First PT/INR home self-testing device with Bluetooth technology enabling remote care programmes for anticoagulated patie...
2016-05-27Roche’s Gazyva/Gazyvaro showed superior progression-free survival compared to MabThera/Rituxan in people with previously...
2016-05-19Phase III study of Roche’s Alecensa (alectinib) showed superior efficacy versus crizotinib in Japanese people with a spe...
2016-05-19FDA grants Roche’s cancer immunotherapy Tecentriq (atezolizumab) accelerated approval for people with a specific type of...
2016-05-03Roche highlights personalised medicines and cancer immunotherapies at 2016 American Society of Clinical Oncology (ASCO) ...
2016-04-29CHMP recommends EU approval of Roche’s Gazyvaro for people with previously treated follicular lymphoma
2016-04-29CHMP recommends EU approval for Roche's Avastin in combination with Tarceva for patients with a specific type of advance...
2016-04-19Roche reports solid sales growth in the first quarter of 2016
2016-04-12Roche announces FDA grants Venclexta(venetoclax) accelerated approval for people with hard-to-treat type of chronic lymp...
2016-04-12Roche to present new data at AAN showing superior efficacy of investigational medicine ocrelizumab versus comparators on...
2016-04-11FDA grants priority review for Roche's cancer immunotherapy atezolizumab in specific type of lung cancer
2016-03-31Roche to initiate testing for Zika virus at U.S. Blood Centres under FDA Investigational New Drug Application protocol
2016-03-15FDA grants Roche's Cancer Immunotherapy Atezolizumab priority review for advanced bladder cancer
2016-03-01Roche Annual General Meeting 2016
2016-02-29FDA approves Roche's Gazyva (obinutuzumab) for certain people with previously treated follicular lymphoma
2016-02-29Roche provides update on two identical phase III studies of lebrikizumab in people with severe asthma
2016-02-17U.S. FDA grants Breakthrough Therapy Designation for Roche's investigational medicine ocrelizumab in primary progressive...
2016-01-28Changes to the Roche Corporate Executive Committee
2016-01-28Roche reports strong results in 2015
2016-01-13One-hour diagnosis of heart attack possible with troponin T test from Roche
2016-01-08Roche presents updated results for investigational cancer immunotherapy atezolizumab in advanced bladder cancer
2016-01-07PROGNOSIS Study Published in The New England Journal of Medicine Reveals Innovative Roche Blood Test Can Be Used as a Pr...
2015-12-14FDA grants Roche's Alecensa (alectinib) accelerated approval for people with a specific type of lung cancer
2015-12-07New data from pivotal study showed Roche’s Gazyva/Gazyvaro induced deep remissions and provided meaningful quality of li...
2015-12-07Pivotal Phase II study showed nearly 80 percent of people with hard-to-treat type of chronic lymphocytic leukaemia respo...
2015-12-07Changes in Roche Board of Directors
2015-12-05New results from CLL11 study show Gazyva/Gazyvaro provided people with previously untreated chronic lymphocytic leukaemi...
2015-11-25Roche receives EU approval of Cotellic for use in combination with Zelboraf in advanced melanoma
2015-11-23Updated data showed Cotellic in combination with Zelboraf helped people with a specific type of advanced melanoma live s...
2015-11-12Roche to restructure its manufacturing network for small molecules
2015-11-11FDA approves Roche's Cotellic (cobimetinib) in combination with Zelboraf (vemurafenib) in advanced melanoma
2015-11-09Roche launches new H&E tissue staining solution - the VENTANA HE 600 system
2015-11-05Roche to present new clinical data across a variety of blood diseases at American Society of Hematology 2015 Annual Meet...
2015-11-03Roche expands cobas 4800 System menu with HIV-1, HCV and HCV Genotyping Tests
2015-10-22Roche delivers strong sales growth in the first nine months of 2015
2015-10-19Roche receives FDA approval for viral load tests and cobas 6800/8800 Systems
2015-10-12Roche Wins the first HPV Primary Screening Tender in Europe
2015-10-08Roche's ocrelizumab first investigational medicine to show positive pivotal study results in both relapsing and primary ...
2015-10-05Roche launches the new cobas c 513 analyser, meeting increasing demand for HbA1c testing of people with diabetes
2015-09-29New Roche Esbriet data show clinical benefits of continued and long-term treatment in patients with idiopathic pulmonary...
2015-09-28Roche launches the cobas EGFR Mutation Test v2 for use with either plasma or tumour tissue samples
2015-09-28Roche's ocrelizumab first investigational medicine to show efficacy in people with primary progressive multiple sclerosi...
2015-09-27Roche presents positive results from pivotal study of investigational immunotherapy atezolizumab in specific type of adv...
2015-09-27Two positive studies of Roche’s investigational cancer immunotherapy atezolizumab in specific type of lung cancer presen...
2015-09-25CHMP recommends EU approval for Roche's combination of Cotellic (cobimetinib) and Zelboraf (vemurafenib) in advanced mel...
2015-09-22Roche receives FDA CLIA waiver for flu A/B test for use on its cobas Liat PCR System
2015-09-21New data will be presented for Roche's Esbriet in idiopathic pulmonary fibrosis at European Respiratory Society Congress...
2015-09-11For the 7th year running, Roche ranked most sustainable healthcare company in the Dow Jones Sustainability Indices
2015-09-08Roche to present data from 15 medicines across its portfolio of cancer immunotherapy and targeted medicines during the 2...
2015-09-04US FDA grants breakthrough therapy designation for Roche's investigational medicine ACE910 for people with haemophilia A...
2015-08-19Roche to acquire Kapa Biosystems to strengthen next-generation sequencing product offerings
2015-08-17Pivotal Phase II study showed Roche's investigational immunotherapy atezolizumab shrank tumours in people with a specifi...
2015-08-13Roche acquires GeneWEAVE to strengthen offerings in microbiology diagnostics
2015-08-12Pivotal Phase II study of investigational medicine venetoclax met primary endpoint in a hard-to-treat type of chronic ly...
2015-08-11"Roche Continents" fosters innovation in science and art
2015-07-31Roche's Perjeta regimen approved in Europe for use before surgery in early stage aggressive breast cancer
2015-07-23Roche delivers strong performance in the first half of 2015
2015-07-22Roche Diagnostics strengthens its blood screening portfolio with an assay to identify Human T-lymphotropic virus I/II (H...
2015-07-13In a pivotal study, Roche’s investigational immunotherapy atezolizumab shrank tumours in people with a specific type of ...
2015-06-30Roche’s ocrelizumab significantly reduced both relapses and disability progression versus interferon beta-1a (Rebif®) in...
2015-06-29Roche launches improved point-of-care test to help diagnose high risk heart attack patients with greater accuracy
2015-06-29Roche launches point-of-care (POC) troponin test with improved accuracy at low concentrations to help diagnose heart att...
2015-06-26Roche’s Perjeta recommended for approval in EU for use before surgery in HER2-positive early breast cancer
2015-06-16Roche employees unite to raise funds for children in need
2015-06-10Roche receives U.S. FDA breakthrough therapy designation for ACTEMRA/RoACTEMRA in systemic sclerosis, and will present n...
2015-06-01Roche’s Perjeta regimen helped people with HER2-positive early breast cancer live longer without their disease returning...
2015-05-30Updated data showed Roche’s investigational combination of cobimetinib and Zelboraf (vemurafenib) helps people with adva...
2015-05-30Roche’s Gazyva/Gazyvaro extended the time people with refractory indolent non-Hodgkin’s lymphoma lived without their dis...
2015-05-27Roche to announce new data in rheumatoid arthritis and severe inflammatory disorders at the European League Against Rheu...
2015-05-19Roche Receives FDA CLIA Waiver for the cobas Liat PCR System and Strep A assay
2015-05-14Roche’s investigational medicine alectinib shrank tumours in nearly half of people with specific type of lung cancer
2015-05-14Roche’s investigational immunotherapy MPDL3280A doubled the likelihood of survival compared with chemotherapy in people ...
2015-05-11Pivotal data for Roche medicines in lung and blood cancers to be presented at ASCO
2015-05-08Change in Roche Board of Directors
2015-04-22Roche reports strong sales growth in the first quarter of 2015
2015-04-14Roche announces final results of tender offer for Foundation Medicine, Inc.
2015-04-08EU approves Roche's Avastin plus chemotherapy for women with advanced cervical cancer
2015-04-07Roche announces preliminary results of tender offer for Foundation Medicine, Inc.
2015-03-20Roche announces global distribution agreement for its Biochemical Reagents product portfolio with Sigma-Aldrich
2015-03-17Roche launches next-generation duplex test for parvovirus B19 and hepatitis A in markets accepting the CE mark
2015-03-17Roche launches next-generation duplex test for parvovirus B19 and hepatitis A in markets accepting the CE mark
2015-03-03Roche Annual General Meeting 2015
2015-03-02Roche launches next-generation viral load assay for HBV in markets accepting the CE mark
2015-03-02Roche extends tender offer for FMI
2015-02-27Roche’s Avastin plus chemotherapy receives positive recommendation from CHMP for EU approval in advanced cervical cancer
2015-02-10Roche acquires Signature Diagnostics to advance translational research for next generation sequencing (NGS) diagnostics
2015-02-09FDA approves Roche's Lucentis (ranibizumab injection) for treatment of diabetic retinopathy in people with diabetic macu...
2015-02-04Roche's Phase III study of Gazyva/Gazyvaro showed significant benefit in refractory indolent non-Hodgkin's lymphoma
2015-02-02U.S. FDA grants Breakthrough Therapy Designation for Roche's investigational cancer immunotherapy MPDL3280A (anti-PDL1) ...
2015-02-02Roche commences tender offer for up to 15,604,288 shares of Foundation Medicine, Inc. for $50.00 per share in cash
2015-01-29Roche and Qualcomm collaborate to innovate remote patient monitoring
2015-01-28Roche delivers solid results in 2014
2015-01-27Ventana seeks FDA premarket approval for ALK IHC companion diagnostic to benefit lung cancer patients
2015-01-27Roche receives FDA clearance for next generation cobas MRSA/SA Test
2015-01-16Roche acquires Trophos to expand portfolio in neuromuscular disease with high medical need
2015-01-14Roche licenses additional EGFR pathway-related intellectual property to QIAGEN
2015-01-13Roche, Meiji and Fedora join forces to tackle increasing bacterial resistance to antibiotics
2015-01-12Roche enters a broad strategic collaboration with Foundation Medicine in the field of molecular information in oncology
2015-01-09FDA Approves Roche's Blood Screening Assay for Simultaneous Detection and Identification of Three Major Viral Targets
1970-01-01\u003cstrong\u003eMundipharma to launch \u003cem\u003eTruxima\u003c/em\u003e®▼ (rituximab), the first biosimilar monoclo... (PDF)
Brought to you by PharmiWeb.com - Latest Jobs in Pharma
Brought to you by www.pharmiweb.com - Latest Jobs in Pharma.